International Journal of Risk & Safety in Medicine 22 (2010) 89-92.
Peter R. Breggin
Abstract: Electroconvulsive therapy (ECT) and the machines that deliver it have never been tested for safety and efficacy in order to receive approval from the FDA. The American Psychiatric Association and ECT advocates protested when the FDA took steps to classify the machines as posing “an unreasonable risk of illness or injury”, which would have required their testing before approval. Without requiring this testing, the FDA is now preparing to classify the treatment and the machines as safe. This article reviews evidence demonstrating that ECT is very harmful to the brain and mind, and concludes that the FDA should demand the usual testing, starting with animals, that is required before psychiatric treatments and machines are approved for marketing and use.
"The Need for Ethical Human Sciences and Services." Ethical Human Sciences and Services, 1:3-6, 1999.
"The NIMH Multimodal Study of Treatment for Attention-Deficit/Hyperactivity Disorder: A Critical Analysis." International Journal of Risk and Safety in Medicine, 13:15-22, 2000. Originally published in Ethical Human Sciences and Services, 2:63-72, 2000.
"The Psychiatric Drugging of Toddlers." Ethical Human Sciences and Services, 2: 83-86, 2000.
"The Psychophysiology of Anxiety." Journal of Nervous Mental Diseases 139:558-568, 1964.
"The Return of ECT." Readings: A Journal of Reviews and Commentary in Mental Health, 3 (March#1), 12-17, 1992.
"The Return of Lobotomy and Psychosurgery." Reprinted with a new introduction in Edwards RB (ed): Psychiatry and Ethics. Buffalo, Prometheus Books, 1982. Originally published in the Congressional Record , February 24, 1972, E1602-E1612. First reprinted in Quality of Health Care-Human Experimentation: Hearings Before Senator Edward Kennedy's Subcommittee on Health, US Senate, Washington, D.C., US Government Printing Office, 1973.
The Rights of Children and Parents In Regard to Children Receiving Psychiatric Diagnoses and Drugs. Children & Society, 28, (2014) pp. 231-241
Peter R. Breggin, MD
Based on the author's extensive clinical, forensic and research experience, this article addresses the scientific and moral question of whether it is ever in the best interests of a child to be given a psychiatric drug. The focus is on the diagnosis Attention Deficit Hyperactivity Disorder (ADHD) and stimulant drugs, and on the diagnosis Bipolar Disorder and antipsychotic (neuroleptic) drugs. The conclusion is that we should work towards a prohibition against giving psychiatric drugs to children, and instead focus on safe and effective alternative ways of meeting the needs of children within their families, schools and society. © 2014 John Wiley & Sons Ltd and National Children's Bureau.
Breggin, P.R. (1973).The Second Wave of Psychosurgery." M/H (Mental Health) 57:10-13.
LOBOTOMY and psychosurgery are upon us again! In Philadelphia a black man dies of an overdose of heroin, and a reporter notices peculiar scars on his head. A portion of his brain has been burned out in an experimental attempt to cure his addiction. The neurosurgeon is located by the reporter and admits that his monkey experiments were inconclusive before trying his operation on human addicts.
"The Sedative-like Effect of Epinephrine." Archives of General Psychiatry 12:255-259, 1965.